Tag: Theravance’s

Reuters

US FDA approves Glaxo, Theravance's Breo Ellipta asthma drug Reuters (Reuters) – The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger … GlaxoSmithKline plc (ADR) Gets FDA Approval For Breo Ellipta To Treat Asthma …Bidness ETC FDA Okays Breo Ellipta for Asthma in AdultsMedscape Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg WRAL Tech Wire all 65 news articles »

View full post on asthma – Google News

Reuters

FDA approves Glaxo, Theravance's Breo Ellipta asthma drug Reuters (Reuters) – The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger … Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the USMarketWatch FDA Okays Breo Ellipta for Asthma in AdultsMedscape StreetInsider.com –CNNMoney –HCPLive all 23 news articles »

View full post on asthma – Google News